Bladder Cancer

CHF 203.55
Auf Lager
SKU
KMM26D18UF0
Stock 1 Verfügbar
Geliefert zwischen Mi., 26.11.2025 und Do., 27.11.2025

Details

Michael J. Droller, MD and a panel of experienced clinicians bring their strong background in clinical research to bear on the assessment and management of bladder cancer. Their comprehensive discussion summarizes the state-of-the-art in diagnosis and treatment, based on the latest understanding of bladder cancer's epidemiology, carcinogenesis, and tumor markers. Topics of particular interest include the role of genetics and molecular biology in evaluating bladder cancer clinically, the evaluation of the results of systemic treatment in advanced disease, the current status of tumor markers in bladder cancer, and the means for further study in their applicability. Insightful and evidenced-based, Bladder Cancer: Current Diagnosis and Treatment provides active clinicians and clinical investigators with not only a critical survey of the rapidly expanding research in the area, but also a state-of-the-art tutorial on today's optimal assessment and treatment of bladder cancer.

Includes supplementary material: sn.pub/extras

Klappentext
The increasing incidence of bladder cancer in the United States and worldwide offers an excellent opportunity to better understand the biology of this cancer and to apply clinically relevant research in the treatment room. In Bladder Cancer: Current Diagnosis and Treatment, Michael J. Droller and a panel of experienced clinicians and researchers bring their strong background in clinical research to bear on the assessment and management of this important disease. Their comprehensive discussion summarizes the state-of-the-art in diagnosis and treatment, based on the latest understanding of bladder cancer's epidemiology, carcinogenesis, genetics, and tumor markers. Topics of particular interest include the role of genetics and molecular biology in evaluating bladder cancer clinically, the evaluation of the results of systemic treatment in advanced disease, the current status of tumor markers in bladder cancer, and the means for further study of their applicability.

Insightful and evidenced-based, Bladder Cancer: Current Diagnosis and Treatment provides active clinicians and clinical investigators with not only a critical survey of the rapidly expanding research in the area, but also a state-of-the-art tutorial on today's optimal assessment and treatment of bladder cancer.

Zusammenfassung
Insightful and evidenced-based, Bladder Cancer: Current Diagnosis and Treatment provides active clinicians and clinical investigators with not only a critical survey of the rapidly expanding research in the area, but also a state-of-the-art tutorial on today's optimal assessment and treatment of bladder cancer.

Inhalt
1 Demographic and Epidemiologic Aspects of Bladder Cancer.- 2 Biology and Molecular Aspects of Development and Progression of Bladder Cancer.- 3 Diagnosis of Bladder Cancer.- 4 Diagnostic Imaging in Urothelial Cancer.- 5 Urinary Cytology and its Role in Diagnosis and Monitoring of Urothelial Carcinoma.- 6 The Use of Tumor Markers in Bladder Cancer and Current Concepts on Clinical Applicability.- 7 Pathologic Assessment of Bladder Cancer and Pitfalls in Staging.- 8 Intravesical Chemotherapy in the Treatment of Superficial Bladder Cancer.- 9 Use of Intravesical BCG in Treatment of Superficial Bladder Cancer.- 10 Radical Cystectomy and Pelvic Lymphadenectomy in the Treatment of Infiltrative Bladder Cancer.- 11 Considerations in the Use of Neoadjuvant and Adjunctive Systemic Chemotherapy in Treatment of Invasive Bladder Cancer by Cystectomy.- 12 Clinical Situations for the Role of Radiation Therapy in the Treatment of Bladder Cancer.- 13 Current Concepts of Urinary Diversion in Men.- 14 Current Concepts of Urinary Diversion in Women.- 15 Current Prospects for the Use of Molecular Markers in Treatment of Bladder Cancer by Cystectomy or Bladder-Conserving Approaches.- 16 New Possibilities in Systemic Treatment for Metastatic Bladder Cancer.- 17 Statistical Considerations in the Phase II Evaluation of New Therapies.

Weitere Informationen

  • Allgemeine Informationen
    • Sprache Englisch
    • Editor Michael J. Droller
    • Titel Bladder Cancer
    • Veröffentlichung 19.11.2010
    • ISBN 1617372021
    • Format Kartonierter Einband
    • EAN 9781617372025
    • Jahr 2010
    • Größe H229mm x B152mm x T26mm
    • Untertitel Current Diagnosis and Treatment
    • Gewicht 672g
    • Auflage Softcover reprint of hardcover 1st edition 2001
    • Genre Medizin
    • Lesemotiv Verstehen
    • Anzahl Seiten 468
    • Herausgeber Humana Press
    • GTIN 09781617372025

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470